AAAAAA
Results: 1-25/38
Authors:
MONTGOMERY HE
KIERNAN LA
WHITWORTH CE
FLEMING S
UNGER T
GOHLKE P
MULLINS JJ
MCEWAN JR
Citation: He. Montgomery et al., INHIBITION OF TISSUE ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY PREVENTS MALIGNANT HYPERTENSION IN TGR(MREN2)27, Journal of hypertension, 16(5), 1998, pp. 635-643
Authors:
GOHLKE P
PEES C
UNGER T
Citation: P. Gohlke et al., AT(2) RECEPTOR STIMULATION INCREASES AORTIC CYCLIC-GMP IN SHRSP BY A KININ-DEPENDENT MECHANISM, Hypertension, 31(1), 1998, pp. 349-355
Authors:
PINTO YM
TIAN XL
GOHLKE P
PAUL M
Citation: Ym. Pinto et al., A 40-FOLD INCREASE IN CARDIAC ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY FAILS TO INCREASE LOCAL ANGIOTENSIN-II CONCENTRATIONS, Circulation, 98(17), 1998, pp. 2064-2064
Authors:
CSIKOS T
BALMFORTH AJ
GROJEC M
GOHLKE P
CULMAN J
UNGER T
Citation: T. Csikos et al., ANGIOTENSIN AT(2) RECEPTOR DEGRADATION IS PREVENTED BY LIGAND OCCUPATION, Biochemical and biophysical research communications, 243(1), 1998, pp. 142-147
Authors:
LINZ W
WIEMER G
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., CONTRIBUTION OF KININS TO THE CARDIOVASCU LAR ACTIONS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, PART-III, Perfusion, 10(12), 1997, pp. 439
Authors:
LINZ W
WIEMER G
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., CONTRIBUTION OF KININS TO THE CARDIOVASCU LAR ACTIONS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS .2., Perfusion, 10(11), 1997, pp. 397-402
Authors:
LINZ W
WIEMER G
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., CONTRIBUTION OF KININS TO THE CARDIOVASCU LAR ACTIONS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS .1., Perfusion, 10(10), 1997, pp. 353
Authors:
GOHLKE P
PEES C
UNGER T
Citation: P. Gohlke et al., AT(2) RECEPTOR STIMULATION INCREASES AORTIC CYCLIC-GMP IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS BY A KININ-DEPENDENT MECHANISM, Hypertension, 30(3), 1997, pp. 24-24
Authors:
GOHLKE P
KUWER I
SCHNELL A
AMANN K
MALL G
UNGER T
Citation: P. Gohlke et al., BLOCKADE OF BRADYKININ B-2 RECEPTORS PREVENTS THE INCREASE IN CAPILLARY DENSITY-INDUCED BY CHRONIC ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR TREATMENT IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS, Hypertension, 29(1), 1997, pp. 478-482
Authors:
WHITWORTH C
MONTGOMERY H
KIERNAN L
FLEMING S
UNGAR T
GOHLKE P
MCEWAN J
MULLINS J
Citation: C. Whitworth et al., AN INTACT TISSUE RAS IS REQUIRED FOR THE TRANSITION TO MALIGNANT HYPERTENSION, Kidney international, 52(1), 1997, pp. 269-269
Authors:
GOHLKE P
EDLING O
BUI KL
UNGER T
Citation: P. Gohlke et al., LONG-TERM HYPOTENSIVE EFFECTS OF DIFFERENT ACE-INHIBITORS DO NOT CORRELATE WITH THE REDUCTION OF PLASMA ANGIOTENSIN-II AND INHIBITION OF ACE ACTIVITY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 282-282
Authors:
ITO K
ZHU YZ
ZHU YC
GOHLKE P
UNGER T
Citation: K. Ito et al., CONTRIBUTION OF BRADYKININ TO THE CARDIOPROTECTIVE ACTION OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN HYPERTENSION AND AFTER MYOCARDIAL-INFARCTION, Japanese Journal of Pharmacology, 75(4), 1997, pp. 311-318
Authors:
ZHU YC
ZHU YZ
GOHLKE P
STAUSS HM
UNGER T
Citation: Yc. Zhu et al., EFFECTS OF ANGIOTENSION-CONVERTING ENZYME-INHIBITION AND ANGIOTENSIN-II AT(1) RECEPTOR ANTAGONISM ON CARDIAC PARAMETERS IN LEFT-VENTRICULARHYPERTROPHY, The American journal of cardiology, 80(3A), 1997, pp. 110-117
Authors:
UNGER T
CHUNG O
CSIKOS T
CULMAN J
GALLINAT S
GOHLKE P
HOHLE S
MEFFERT S
STOLL M
STROTH U
ZHU YZ
Citation: T. Unger et al., ANGIOTENSIN RECEPTORS, Journal of hypertension, 14, 1996, pp. 95-103
Authors:
TSCHOPE C
REINECKE A
YU MH
SEIDL U
RIESTER U
GAVRILUK V
GRAF K
GOHLKE P
HILGENFELDT U
RITZ E
UNGER T
Citation: C. Tschope et al., THE ROLE OF KININ-DEGRADING ENZYMES ON THE REGULATION OF THE KALLIKREIN-KININ SYSTEM IN EXPERIMENTAL DIABETES, Hypertension, 28(4), 1996, pp. 702-702
Authors:
GOHLKE P
KUWER I
SCHNELL A
AMANN K
MALL G
UNGER T
Citation: P. Gohlke et al., BLOCKADE OF BRADYKININ B-2-RECEPTORS PREVENTS THE INCREASE IN CAPILLARY DENSITY-INDUCED BY CHRONIC ACE-INHIBITOR TREATMENT IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS, Hypertension, 28(3), 1996, pp. 104-104
Authors:
GOHLKE P
LINZ W
SCHOLKENS BA
WIEMER G
UNGER T
Citation: P. Gohlke et al., CARDIAC AND VASCULAR EFFECTS OF LONG-TERM LOSARTAN TREATMENT IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS, Hypertension, 28(3), 1996, pp. 397-402
Authors:
DATTE JY
GOHLKE P
ZIEGLER A
Citation: Jy. Datte et al., ANGIOTENSIN-II AFFECTS THE CONTRACTILE RESPONSES TO NORADRENALINE IN THE PRESENCE OF ERGOTAMINE IN VENA PORTAE PREPARATIONS, The Journal of general physiology, 108(2), 1996, pp. 58-58
Authors:
ZHU YC
ZHU YZ
SPITZNAGEL H
GOHLKE P
UNGER T
Citation: Yc. Zhu et al., SUBSTRATE METABOLISM, HORMONE INTERACTION, AND ANGIOTENSIN-CONVERTINGENZYME-INHIBITORS IN LEFT-VENTRICULAR HYPERTROPHY, Diabetes, 45, 1996, pp. 59-65
Authors:
LINZ W
WIEMER G
SCHAPER J
ZIMMERMANN R
NAGASAWA K
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, LEFT-VENTRICULAR HYPERTROPHY AND FIBROSIS, Molecular and cellular biochemistry, 147(1-2), 1995, pp. 89-97
Authors:
GOHLKE P
LINZ W
SCHOLKENS BA
KUWER I
BARTENBACH S
SCHNELL A
UNGER T
Citation: P. Gohlke et al., CHRONIC ANGIOTENSIN AT RECEPTOR BLOCKADE IMPROVES CARDIAC-FUNCTION AND METABOLISM IN SHRSP, Hypertension, 26(3), 1995, pp. 563-563
Authors:
LINZ W
WIEMER G
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., CONTRIBUTION OF KININS TO THE CARDIOVASCULAR ACTIONS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, Pharmacological reviews, 47(1), 1995, pp. 25-49
Authors:
EDLING O
BAO G
FEELISCH M
UNGER T
GOHLKE P
Citation: O. Edling et al., MOEXIPRIL, A NEW ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR - PHARMACOLOGICAL CHARACTERIZATION AND COMPARISON WITH ENALAPRIL, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 854-863
Authors:
ZHU YC
STAUSS HM
BAO G
GOHLKE P
ZHU YZ
REDLICH T
UNGER T
Citation: Yc. Zhu et al., ROLE OF BRADYKININ IN THE ANTIHYPERTENSIVE AND CARDIOPROTECTIVE ACTIONS OF CONVERTING-ENZYME INHIBITORS, Canadian journal of physiology and pharmacology, 73(7), 1995, pp. 827-831
Authors:
LINZ W
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., EXPERIMENTAL-EVIDENCE FOR EFFECTS OF RAMIPRIL ON CARDIAC AND VASCULARHYPERTROPHY BEYOND BLOOD-PRESSURE REDUCTION, Archives des maladies du coeur et des vaisseaux, 88, 1995, pp. 31-34